Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Uncovering Cellular Mechanisms of Genetic Skin Diseases
Disease Discoveries

Uncovering Cellular Mechanisms of Genetic Skin Diseases

By Melissa RohmanJan 11, 2022
Share
Facebook Twitter Email
Kathleen Green, PhD, the Joseph L. Mayberry, Sr., Professor of Pathology and Toxicology and a professor of Dermatology, was senior author of the study published in the Journal of Clinical Investigation.

Northwestern Medicine investigators have discovered a novel mechanism linking an intercellular adhesion molecule with genetic inflammatory skin diseases, according to findings published in the Journal of Clinical Investigation.

The study, led by Kathleen Green, PhD, the Joseph L. Mayberry, Sr., Professor of Pathology and Toxicology and a professor of Dermatology, suggests that Desmoglein-1 (Dsg1) deficiency results in an inflammatory gene signature that is seen in patients diagnosed with skin diseases such as psoriasis and may be a promising therapeutic target.

Dsg1 is a cadherin, a cell-to-cell adhesion molecule and key component of the desmosome, a complex that helps tissues withstand mechanical and environmental stressors. Dsg1 is expressed exclusively within the upper layers of the skin’s most outer layer, the epidermis.

Previous work suggests that mutations in Dsg1 and ultimately its loss of function are associated with chronic inflammation and the manifestation of skin lesions and allergies. However, the precise intracellular mechanisms that cause this deficiency remained unknown.

Lisa Godsel, ’97 PhD, research assistant professor of Pathology and of Dermatology, was a co-lead author of the study along with Quinn Roth-Carter, PhD, a postdoctoral fellow in the Green laboratory.

To uncover these mechanisms, the investigators used gene editing methods to delete Dsg1 from mice genomes. The gene expression profiles of the mice were then compared to the profiles of patients with severe dermatitis, multiple allergies and metabolic wasting (SAM) syndrome, a rare, genetic skin disease caused by Dsg1 deficiency that results in a severe thickening of the skin and increased inflammation.

The team found similarities between the genetic profiles of the mice and patients, specifically a shared IL-17/IL-23 inflammatory signature and impaired intercellular adhesion caused by the loss of Dsg1 at the surface of cells in the epidermis. IL-17 is secreted by T-cells involved in the body’s inflammatory response. This inflammatory signature was also similar to that seen in patients with psoriasis, the authors found.

Further demonstrating the relevance of their findings in vivo, two Dsg1-deficient patients with SAM syndrome were treated with ustekinumab, an immunosuppressive drug commonly prescribed to treat psoriasis. The drug inhibits IL-12/IL-23 cytokine activity, which is involved in the body’s inflammatory response. After 10 months of treatment, both patients experienced significant improvement of pre-existing skin lesions.

“We’ve only begun to scratch the surface and now we’re interested in how much Dsg1 might be playing a role in other skin diseases,” said Lisa Godsel, ’97 PhD, research assistant professor of Pathology, of Dermatology and co-lead author of the study.

Immunostaining of protein constituents of the cell-cell adhesive junction in the desmosome in skin biopsies taken from a patient with SAM syndrome harboring a genetic mutation in Dsg1. The levels of Dsg1 and its associated partner protein plakoglobin (PG) are restored at cell borders following ustekinumab treatment.

At the very least, Dsg1 expression could serve as a biomarker that can be used to improve treatment of genetic skin diseases, Godsel added. Furthermore, a topical treatment that can help increase the expression of Dsg1 in the skin would be a game changer in treating these diseases.

“If we can actually improve Dsg1 expression, we might be able to target all these diseases that have a Dsg1 decrease,” Green said.

Quinn Roth-Carter, PhD, a postdoctoral fellow in the Green laboratory, was co-lead author of the study. Co-authors include Joshua Broussard, PhD, research assistant professor of Pathology and of Dermatology; Marihan Hegazy, a student in the Driskill Graduate Program in Life Sciences (DGP); Jodi Lynn Johnson, PhD, research assistant professor of Pathology and of Dermatology; Lynn Doglio, PhD, research associate professor of Pharmacology; Rajeshwar Awatramani, PhD, professor in the Ken and Ruth Davee Department of Neurology Division of Movement Disorders; and Xiaomin Bao, PhD, assistant professor of Dermatology.

Green, Broussard, Johnson, Awatramani and Bao are members of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and Green is the associate director for Basic Sciences Research at the Lurie Cancer Center.

This work was supported by the National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases grants R01 AR041836 and R01 AR075015, NIH grant R37 AR43380, National Cancer Institute grant R01 CA228196, a Leo Foundation Grant, NIH T32 Training grants CA070085 and CA009560, a JL Mayberry endowment, and NIH grant K01 AR075087.

Cancer Dermatology Pathology Research
Share. Facebook Twitter Email

Related Posts

How ChatGPT Has, and Will Continue to, Transform Scientific Research

Mar 21, 2023

New Directions for HIV Treatment

Mar 21, 2023

Humans are Not Just Big Mice: Identifying Science’s Muscle-Scaling Problem

Mar 20, 2023

Comments are closed.

Latest News

How ChatGPT Has, and Will Continue to, Transform Scientific Research

Mar 21, 2023

New Directions for HIV Treatment

Mar 21, 2023

Humans are Not Just Big Mice: Identifying Science’s Muscle-Scaling Problem

Mar 20, 2023

AOA Honors New Members

Mar 20, 2023

Celebrating Feinberg’s 2023 Match Day

Mar 17, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230315_NM036
20230315_NM046
20230315_NM134
20230315_NM205
20230315_NM206
20230315_NM132
20230315_NM130
20230315_NM082
20230315_NM063
20230315_NM058
20230315_NM030
20230315_NM038

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.